The authors of this paper apologise for having to report an error in Figure 3 and Table 2 . The corrected figure and table are presented below.
Moreover, due to a regrettable mix-up in the ordering procedures, the sequences of h32DYSF1 and h34DYSF2 have been swapped (Table 2 ) -h32DYSF1 targets exon 34 and h34DYSF2 targets exon 32. We refer to our correspondence with Levy et al in this issue. The applicability is based on the mutations reported in the DYSF database (http://www.dmd.nl). As most patients have heterozygous mutations, the total applicability is 4100%. c Indicates which exons make good targets on a scale of 1-9, where 1 is optimal and 9 is least optimal; NA stands for unsuitable exons.
